Johnson & Johnson

Johnson & Johnson

Johnson & Johnson’s $13b bid to settle cancer claims is being seen as a 'massive gamble'. The company's first attempt to use bankruptcy to avoid claims that its baby powder caused cancer failed, drawing public criticism. Now, Johnson & Johnson is trying again to settle these claims.

This move comes after the company faced backlash for its previous tactics. The outcome of this latest bid remains uncertain, but it is clear that Johnson & Johnson is taking a significant risk in attempting to resolve these cancer claims.